initiative OCTALFA’s mission is two fold: facilitate innovation in healthcare and provide support to vulnerable people.

Initiative OCTALFA works to bring about innovation in healthcare by incubating innovative startups in France.

Initiative OCTALFA also supports projects aimed at improving quality of life for cancer patients and disabled people in France and Madagascar.


OCTALFA creates, funds and manages young innovative companies
OTONNALE identify innovative projects until they mature into fledgling companies
The corporate foundation Fondation Dominique & Tom Alberici – OCTALFA supports charity and non-profit projects addressing the challenges surrounding cancer and disabilities in France and Madagascar
The endowment fund Institut Dominique & Tom Alberici raises additional funds for projects supported by our corporate foundation


  • Gilles Alberici

    Gilles has 30 years of experience in the pharmaceutical and biotechnology sectors. He created and developedOPi, Pharmaceuticals for Rare Diseases and has taken more than ten products through clinical trials.

  • Julien Alberici
    Managing Director

    Julien is a graduate of EMLYON Business School and iaelyon management school. He has worked as a consultant in innovation management, business development andfinancial analysis,and is currently the Chief Executive Officer and co-founder ofMathym.

  • Jeremy Bastid
    R&D Director

    Jeremy is a pharmacist and oncologist, who specialises in immuno-oncology. He joined initiative OCTALFA in 2010 and manages OREGA Biotech as Chief Operating Officer.

  • Charlotte Maddalena
    Executive Assistant

    Charlotte Maddalena joined initiative OCTALFA in October 2016 as an executive assistant. Charlotte is also responsible for the administrative management of the Foundation’s projects.

  • Laurence Simon
    Administrative and Financial Director

    Laurence Simon is Administrative and Financial Director. She has more than 15 years of experience in the biotechnology sector where she worked for OPI, Eusa Pharma and Jazz Pharmaceuticals as Financial Director. She joined the initiative Octalfa team on November 3, 2016.


Formed in 2006, OCTALFA is the fruit of previous work carried out by Gilles Alberici, in particular during his time at OPi, a company that develops drugs for orphan diseases.

OCTALFA began by helping established innovative companies with financing operations. It founded and/or invested in 14 companies in France. Since 2016, OCTALFA concentrates its efforts to the development and management of its subsidiaries.

OTONNALE identify innovative industrial or academic projects before the inception of a company dedicated to their management.

Spearheaded by Dominique Alberici, OCTALFA created the OCTALFA Corporate Foundation in 2008 to provide help for cancer patients and disabled people. The corporate foundation was named Fondation Dominique & Tom Alberici – OCTALFA in 2011, following the passing away of Tom, Dominique and Gilles’ son.

Founded in 2012, the endowment fund Institut Dominique & Tom Alberici complements the corporate foundation’s activities by supporting charity projects that require both a more hands-on approach and additional funding. This funding is provided by OCTALFA and our donors.


  • July 2018 newsletter

    Read the newsletter of the endowment fund Institut Dominique & Tom Alberici

  • Pierre Attali joins ORPHELIA Pharma Board Of Directors
  • All our projects

  • One project supported by our Endowment Fund

    On 27th of april 2018, the foundation decided to support, throught its endowment fund Institut Dominique & Tom Alberici, Sembana Mijoro, a malagasy center located in Antananarivo, which works for the educational integration of children and young handicapped people. Our support focuses on financing the equipment of activities and outdoor spaces.

  • Two projects supported by our Foundation

    The 27th of april 2018, the board of directors of the Fondation Dominique & Tom Alberici decided to support the Horizon Cancer association by participating in the financing of socio-aesthetic care, and the Institute Plein Vent Deafness, for their equipment in multimedia devices.


  • Quelle Histoire !

    JANUARY 2018

    “Quelle histoire !” association uses tales as therapeutic tool for hospitalized children suffering from cancer, through the project “Ça conte à l’hôpital” (Tales at the hospital). Storytellers propose targeted actions to the patients in collaboration with the hospital professionals, by privileging meetings with the most isolated children.

  • Le sourire d'Onja

    JANUARY 2018

    The goal of the Reunionese association “Le Sourire d’Onja” (Onja’s smile) is to help and support disabled children with cerebral palsy in Antananarivo. The support provided by the Fondation Dominique & Tom Alberici focuses on training and equipping midwives in Madagascar (Antsirabe region) to reduce the risk of cerebral palsy in infants.

  • Meet us at the following congresses in 2018

    Jeremy Bastid will attend the following H1-2018 congresses:

    ANR – Advances in Neuroblastoma Research
    San Francisco May 9 -12

    ASCO – American Society of Clinical Oncology
    Chicago June 1 – 5

    BIO International Convention – Boston June 4 – 7